vascuCAP vs Withings Scan Monitor
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A (vascuCAP) is an AI-powered software for detailed CT angiography analysis, providing precise plaque quantification and cardiovascular risk assessment to guide treatment decisions. In contrast, Tool B (Withings Scan Monitor) is a device-based solution (smart scales, smartwatches) focused on remote patient monitoring, offering ECG for AFib detection and other vital health metrics for ongoing surveillance. While both utilize AI for cardiovascular health and are FDA-cleared, their distinct data sources and primary applications target different aspects of patient care.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
vascuCAP is designed for non-invasive CT angiography analysis, quantifying plaque composition and assessing cardiovascular risk for stroke and heart attack to optimize treatment decisions for patients with known or suspected cardiovascular disease. In contrast, the Withings Scan Monitor is an AI-powered tool integrated into smart scales and smartwatches, offering FDA-cleared ECG for AFib detection, heart rate, and other vital health metrics for both personal use and professional remote patient monitoring.
vascuCAP utilizes AI-enabled CT angiogram analysis to quantify histologically-validated plaque composition, including lipid-rich necrotic core, calcification, non-calcified matrix, and intraplaque hemorrhage, along with 3D visualization of arterial vessels and plaque. The Withings Scan Monitor gathers data from device-based smart scales and smartwatches to provide 6-lead or single-lead ECG for Atrial Fibrillation (AFib) detection, heart rate, blood oxygen saturation (SpO2), Vascular Age assessment, and Nerve Health Score.
vascuCAP provides risk stratification for stroke and heart attack based on its histologically-validated plaque quantification and characterization from CT angiography. The Withings Scan Monitor primarily focuses on detecting Atrial Fibrillation (AFib) via ECG and offers a Vascular Age assessment, along with monitoring heart rate and irregular rhythm notifications.